Allient (ALNT) Q3 2025 earnings summary

Executive summary

• Achieved 11% year-over-year revenue growth to $138.7 million in Q3 2025, with net income up over 200% to $6.5 million and record gross margin of 33.3%, driven by strong industrial, defense, and medical demand, and efficiency initiatives from the Simplify to Accelerate NOW program.

• Operating income rose to $12.2 million (8.8% of revenue), with operating margin expanding 350 basis points year-over-year, reflecting mix shift to higher-value programs and cost discipline.

• Adjusted EBITDA increased to $20.3 million (14.6% of revenue), up 41% year-over-year, and adjusted net income was $9.9 million ($0.59 per share).

• Year-to-date cash from operations reached $43.1 million, up 46% year-over-year, enabling net debt reduction of $33.9 million and leverage ratio improvement to 2.1x.

• Strategic initiatives, including the Simplify to Accelerate NOW program and facility realignment, delivered $10 million in annualized savings in 2024, with $6–$7 million more expected in 2025.

Financial highlights

• Q3 2025 revenue was $138.7 million, up $13.5 million or 11% year-over-year, with $2.3 million from FX tailwinds; sequential revenue declined less than 1%.

• Gross profit reached $46.2 million, gross margin expanded to a record 33.3% (up 190 bps YoY), marking the fifth consecutive quarter of margin expansion.

• Net income was $6.5 million ($0.39 per diluted share), up over 200% year-over-year; adjusted net income was $9.9 million ($0.59 per share).

• Adjusted EBITDA for Q3 2025 was $20.3 million (14.6% margin), up 310 bps year-over-year.

• Year-to-date operating cash flow was $43.1 million, up 46% year-over-year; net debt reduced by $33.9 million.

Outlook and guidance

• Backlog ended Q3 at $231 million, with most expected to ship in 3–9 months; book-to-bill ratio was 0.96, impacted by a $5 million M10 Booker tank program cancellation.

• Management expects the full-year 2025 effective tax rate to be 21–23%.

• Capital expenditures for 2025 are projected at $6.5–$8.5 million.

• Management remains confident in demand resiliency, citing a strong quoting pipeline and improving global industrial environment, though uneven.

• Majority of backlog expected to convert to revenue within three to nine months.